Legal Representation
Attorney
Jonathan M. Gelchinsky
USPTO Deadlines
Next Deadline
39 days remaining
Abandonment Notice E-Mailed - Failure to Respond
Due Date
August 24, 2025
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 24, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jun 24, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 10, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 10, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 10, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 27, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 26, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 14, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in treating cancer, namely, lymphoma and leukemia; pharmaceutical preparations for use in treating oncological and hematological diseases and disorders; pharmaceutical preparations for use in treating solid tumors
Class 035
Organizing and recruiting patients for clinical trials for the treatment of cancer, namely, lymphoma and leukemia, hematological diseases and disorders, and solid tumors
Class 042
Scientific research in the nature of conducting clinical trials for the treatment of cancer, namely, lymphoma and leukemia, hematological diseases and disorders, and solid tumors
Class 044
Medical treatment of cancer, namely, lymphoma and leukemia, hematological diseases and disorders, and solid tumors
Additional Information
Design Mark
The mark consists of the stacked wording "CARGO THERAPEUTICS" in stylized letters.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
035
042
044